ReviewCancers2021

Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases.

Brett M Szeligo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.